» Articles » PMID: 23703872

Novel CLCNKB Mutations Causing Bartter Syndrome Affect Channel Surface Expression

Overview
Journal Hum Mutat
Specialty Genetics
Date 2013 May 25
PMID 23703872
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in the CLCNKB gene encoding the ClC-Kb Cl(-) channel cause Bartter syndrome, which is a salt-losing renal tubulopathy. Here, we investigate the functional consequences of seven mutations. When expressed in Xenopus laevis oocytes, four mutants carried no current (c.736G>C, p.Gly246Arg; c.1271G>A, p.Gly424Glu; c.1313G>A, p.Arg438His; c.1316T>C, p.Leu439Pro), whereas others displayed a 30%-60% reduction in conductance as compared with wild-type ClC-Kb (c.242T>C, p.Leu81Pro; c.274C>T, p.Arg92Trp; c.1052G>C, p.Arg351Pro). Anion selectivity and sensitivity to external Ca(2+) and H(+), typical of the ClC-Kb channel, were not modified in the partially active mutants. In oocytes, we found that all the mutations reduced surface expression with a profile similar to that observed for currents. In HEK293 cells, the currents in the mutants had similar profiles to those obtained in oocytes, except for p.Leu81Pro, which produced no current. Furthermore, p.Arg92Trp and p.Arg351Pro mutations did not modify the unit-conductance of closely related ClC-K1. Western blot analysis in HEK293 cells showed that ClC-Kb protein abundance was lower for the nonconducting mutants but similar to wild-type for other mutants. Overall, two classes of mutants can be distinguished: nonconducting mutants associated with low total protein expression, and partially conducting mutants with unaltered channel properties and ClC-Kb protein abundance.

Citing Articles

ClC-K Kidney Chloride Channels: From Structure to Pathology.

Andrini O, Eladari D, Picard N Handb Exp Pharmacol. 2023; 283:35-58.

PMID: 36811727 DOI: 10.1007/164_2023_635.


Functional Study of Novel Bartter's Syndrome Mutations in ClC-Kb and Rescue by the Accessory Subunit Barttin Toward Personalized Medicine.

Sahbani D, Strumbo B, Tedeschi S, Conte E, Camerino G, Benetti E Front Pharmacol. 2020; 11:327.

PMID: 32256370 PMC: 7092721. DOI: 10.3389/fphar.2020.00327.


Splicing Characterization of Variants in Four Patients With Type III Bartter Syndrome.

Wang C, Han Y, Zhou J, Zheng B, Zhou W, Bao H Front Genet. 2020; 11:81.

PMID: 32153641 PMC: 7047732. DOI: 10.3389/fgene.2020.00081.


Mutation spectrum of Chinese patients with Bartter syndrome.

Han Y, Lin Y, Sun Q, Wang S, Gao Y, Shao L Oncotarget. 2017; 8(60):101614-101622.

PMID: 29254190 PMC: 5731900. DOI: 10.18632/oncotarget.21355.


Potassium Homeostasis, Oxidative Stress, and Human Disease.

Udensi U, Tchounwou P Int J Clin Exp Physiol. 2017; 4(3):111-122.

PMID: 29218312 PMC: 5716641. DOI: 10.4103/ijcep.ijcep_43_17.